Personalized medicine in lipid-modifying therapy

Source : https://doi.org/10.2217/pme-2020-0110

The choice of lipid-modifying treatment is largely based on the absolute level of cardiovascular risk and baseline lipid profile. Statins are the first-line treatment for most patients requiring reduction of...

Association of small dense LDL-cholesterol with disease severity, hypertension status and clinical outcome in patients with coronary artery disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33186323/

1 State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. 2 Department of Cardiology, Xuanwu...

Novel Experimental Agents for the Treatment of Hypercholesterolemia | JEP

Source : https://doi.org/10.2147/JEP.S267376

Ivan Pećin, 1, 2 Željko Reiner 1, 2 1Zagreb School of Medicine, University of Zagreb, Zagreb, Croatia; 2Division of Metabolic Diseases, Department of Internal Medicine, University Hospital Center, Zagreb, Croatia...

The Effects of SGLT2 Inhibitors on Lipid Metabolism - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33535652/

Sodium glucose co-transporter 2 (SGLT2) inhibitors are effective antihyperglycemic agents by inhibiting glucose reabsorption in the proximal tubule of the kidney. Besides improving glycemic control in patients with type 2...

Ovarian cancer risk in relation to blood lipid levels and hyperlipidemia: a systematic review and meta-analysis of observational epidemiologic studies - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/32483012/

1 Department of Oncology, Georgetown University School of Medicine, Washington, DC. 2 Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill,...